Screener
Eligibility screening
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
1 US site in AL
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.